IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -94.7% | 88 | -98.4% | 0.00% | -100.0% |
| Q3 2020 | $19,000 | -67.2% | 5,459 | -56.4% | 0.00% | -75.0% |
| Q2 2020 | $58,000 | +176.2% | 12,535 | +82.8% | 0.00% | +100.0% |
| Q1 2020 | $21,000 | -73.1% | 6,859 | -54.5% | 0.00% | -60.0% |
| Q4 2019 | $78,000 | +387.5% | 15,076 | +124.6% | 0.01% | +400.0% |
| Q3 2019 | $16,000 | +1500.0% | 6,711 | +881.1% | 0.00% | – |
| Q2 2019 | $1,000 | -80.0% | 684 | -27.2% | 0.00% | – |
| Q4 2018 | $5,000 | -54.5% | 939 | -24.2% | 0.00% | -100.0% |
| Q3 2018 | $11,000 | -100.0% | 1,238 | -65.3% | 0.00% | -66.7% |
| Q2 2018 | $34,755,000 | +138920.0% | 3,572 | +54.2% | 0.00% | +50.0% |
| Q1 2018 | $25,000 | – | 2,316 | +7620.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 30 | -93.1% | 0.00% | – |
| Q3 2017 | $3,000 | -62.5% | 435 | -62.9% | 0.00% | -100.0% |
| Q2 2017 | $8,000 | -69.2% | 1,172 | -82.7% | 0.00% | -50.0% |
| Q1 2017 | $26,000 | -21.2% | 6,779 | -58.1% | 0.00% | -33.3% |
| Q4 2016 | $33,000 | – | 16,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |